A 52-year-old man drinks 6-8 beers daily and meets criteria for moderate alcohol use disorder. He has no cirrhosis or opioid use and normal liver enzymes. He is motivated to cut down. According to Canadian and international guidance, which pharmacologic option is appropriate first-line to reduce heavy drinking?